234 related articles for article (PubMed ID: 30247603)
1. Impact of Zostavax Vaccination on T-Cell Accumulation and Cutaneous Gene Expression in the Skin of Older Humans After Varicella Zoster Virus Antigen-Specific Challenge.
Patel NP; Vukmanovic-Stejic M; Suarez-Farinas M; Chambers ES; Sandhu D; Fuentes-Duculan J; Mabbott NA; Rustin MHA; Krueger J; Akbar AN
J Infect Dis; 2018 Sep; 218(suppl_2):S88-S98. PubMed ID: 30247603
[TBL] [Abstract][Full Text] [Related]
2. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.
Sullivan NL; Reuter-Monslow MA; Sei J; Durr E; Davis CW; Chang C; McCausland M; Wieland A; Krah D; Rouphael N; Mehta AK; Mulligan MJ; Pulendran B; Ahmed R; Vora KA
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743372
[TBL] [Abstract][Full Text] [Related]
3. Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus.
Laing KJ; Russell RM; Dong L; Schmid DS; Stern M; Magaret A; Haas JG; Johnston C; Wald A; Koelle DM
J Infect Dis; 2015 Oct; 212(7):1022-31. PubMed ID: 25784732
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell Immunity.
Weinberg A; Pang L; Johnson MJ; Caldas Y; Cho A; Tovar-Salazar A; Canniff J; Schmader KE; Popmihajlov Z; Levin MJ
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092579
[TBL] [Abstract][Full Text] [Related]
5. Varicella zoster-specific CD4+Foxp3+ T cells accumulate after cutaneous antigen challenge in humans.
Vukmanovic-Stejic M; Sandhu D; Sobande TO; Agius E; Lacy KE; Riddell N; Montez S; Dintwe OB; Scriba TJ; Breuer J; Nikolich-Zugich J; Ogg G; Rustin MH; Akbar AN
J Immunol; 2013 Feb; 190(3):977-86. PubMed ID: 23284056
[TBL] [Abstract][Full Text] [Related]
6. Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults.
van der Heiden M; de Rond LGH; van Zelm MC; Berbers GAM; Boots AMH; Buisman AM
Front Immunol; 2018; 9():46. PubMed ID: 29410671
[TBL] [Abstract][Full Text] [Related]
7. Identification and Characterization of CD4
Voic H; de Vries RD; Sidney J; Rubiro P; Moore E; Phillips E; Mallal S; Schwan B; Weiskopf D; Sette A; Grifoni A
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999027
[TBL] [Abstract][Full Text] [Related]
8. Varicella-Zoster Virus-Specific Cellular Immune Responses to the Live Attenuated Zoster Vaccine in Young and Older Adults.
Weinberg A; Canniff J; Rouphael N; Mehta A; Mulligan M; Whitaker JA; Levin MJ
J Immunol; 2017 Jul; 199(2):604-612. PubMed ID: 28607114
[TBL] [Abstract][Full Text] [Related]
9. Persistence of Varicella-Zoster Virus-Specific Plasma Cells in Adult Human Bone Marrow following Childhood Vaccination.
Eberhardt CS; Wieland A; Nasti TH; Grifoni A; Wilson E; Schmid DS; Pulendran B; Sette A; Waller EK; Rouphael N; Ahmed R
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321817
[TBL] [Abstract][Full Text] [Related]
10. Quantification of a cell-mediated immune response against varicella zoster virus by assessing responder CD4
Haredy AM; Takei M; Iwamoto SI; Ohno M; Kosaka M; Hirota K; Koketsu R; Okuno T; Ikuta K; Yamanishi K; Ebina H
Vaccine; 2019 Aug; 37(36):5225-5232. PubMed ID: 31358406
[TBL] [Abstract][Full Text] [Related]
11. Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: a randomised non-inferiority clinical trial.
Diez-Domingo J; Weinke T; Garcia de Lomas J; Meyer CU; Bertrand I; Eymin C; Thomas S; Sadorge C
Vaccine; 2015 Feb; 33(6):789-95. PubMed ID: 25555381
[TBL] [Abstract][Full Text] [Related]
12. The Characterization of Varicella Zoster Virus-Specific T Cells in Skin and Blood during Aging.
Vukmanovic-Stejic M; Sandhu D; Seidel JA; Patel N; Sobande TO; Agius E; Jackson SE; Fuentes-Duculan J; Suárez-Fariñas M; Mabbott NA; Lacy KE; Ogg G; Nestle FO; Krueger JG; Rustin MHA; Akbar AN
J Invest Dermatol; 2015 Jul; 135(7):1752-1762. PubMed ID: 25734814
[TBL] [Abstract][Full Text] [Related]
13. Th1 memory differentiates recombinant from live herpes zoster vaccines.
Levin MJ; Kroehl ME; Johnson MJ; Hammes A; Reinhold D; Lang N; Weinberg A
J Clin Invest; 2018 Oct; 128(10):4429-4440. PubMed ID: 30024861
[TBL] [Abstract][Full Text] [Related]
14. Zoster vaccine: current status and future prospects.
Oxman MN
Clin Infect Dis; 2010 Jul; 51(2):197-213. PubMed ID: 20550454
[TBL] [Abstract][Full Text] [Related]
15. The immunogenicity and safety of zoster vaccine in Taiwanese adults.
Yao CA; Chen LK; Huang KC
Vaccine; 2015 Mar; 33(13):1515-7. PubMed ID: 25681662
[TBL] [Abstract][Full Text] [Related]
16. Analysis of T cell responses during active varicella-zoster virus reactivation in human ganglia.
Steain M; Sutherland JP; Rodriguez M; Cunningham AL; Slobedman B; Abendroth A
J Virol; 2014 Mar; 88(5):2704-16. PubMed ID: 24352459
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of glycoprotein E subunit and live attenuated varicella-zoster virus vaccines formulated with a single-strand RNA-based adjuvant.
Lee SJ; Park HJ; Ko HL; Lee JE; Lee HJ; Kim H; Nam JH
Immun Inflamm Dis; 2020 Jun; 8(2):216-227. PubMed ID: 32167678
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine.
Grupping K; Campora L; Douha M; Heineman TC; Klein NP; Lal H; Peterson J; Vastiau I; Oostvogels L
J Infect Dis; 2017 Dec; 216(11):1343-1351. PubMed ID: 29029122
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial.
Trannoy E; Berger R; Holländer G; Bailleux F; Heimendinger P; Vuillier D; Creusvaux H
Vaccine; 2000 Feb; 18(16):1700-6. PubMed ID: 10689152
[TBL] [Abstract][Full Text] [Related]
20. Protocol of a randomised controlled trial characterising the immune responses induced by varicella-zoster virus (VZV) vaccination in healthy Kenyan women: setting the stage for a potential VZV-based HIV vaccine.
Perciani CT; Jaoko W; Walmsley S; Farah B; Mahmud SM; Ostrowski M; Anzala O; Team KI; MacDonald KS
BMJ Open; 2017 Sep; 7(9):e017391. PubMed ID: 28939581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]